Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (321-330 of 404) with videos related to

Pageof 41
Sort By:
Journal of the American Society of Nephrology : JASN|May 16, 2008
Irradiation prolongs survival of Alport miceKan Katayama, Mitsuo Kawano, Ichiro Naito, et al.
Japanese Journal of Ophthalmology|November 13, 2020
Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative studyHiroto Ishikawa, Yoichiro Masuda, Hitoshi Ishikawa, et al.
Journal of Radiation Research|May 28, 2014
High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II studyYoshiko Oshiro, Toshiyuki Okumura, Koichi Kurishima, et al.
Advances in Radiation Oncology|November 17, 2025
Carbon Ion Versus Photon-based Stereotactic Ablative Radiation Therapy for Patients with Choroidal MelanomaJina Kim, Masaru Wakatsuki, Shuri Aoki, et al.
Cancers|September 27, 2025
Carbon-Ion Radiotherapy for Prostate Cancer in Patients with a History of Surgery for Benign Prostatic HyperplasiaAtsushi Okato, Kosei Miura, Tomoki Yamaguchi, et al.
Japanese Journal of Ophthalmology|October 29, 2024
Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in JapanYohei Takahashi, Takeshi Kezuka, Keigo Shikishima, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2023
Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG)Nobuteru Kubo, Hiroaki Suefuji, Mio Nakajima, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Long-Term Outcomes of Ocular and Visual Preservation After Carbon Ion Radiation Therapy for Choroidal Malignant MelanomaShuri Aoki, Masaru Wakatsuki, Hiroshi Tsuji, et al.
International Journal of Clinical Oncology|October 10, 2019
A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinomaYoshiyuki Nagumo, Takahiro Kojima, Masanobu Shiga, et al.
Annals of Clinical Biochemistry|April 4, 2015
Simple quantitation for potential serum disease biomarker peptides, primarily identified by a peptidomics approach in the serum with hypertensive disorders of pregnancyKensuke Hamamura, Daisuke Nonaka, Hitoshi Ishikawa, et al.
Pageof 41

Showing results (321-330 of 404) with videos related to

Sort By:
Pageof 41
Journal of the American Society of Nephrology : JASN|May 16, 2008
Irradiation prolongs survival of Alport miceKan Katayama, Mitsuo Kawano, Ichiro Naito, et al.
Japanese Journal of Ophthalmology|November 13, 2020
Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative studyHiroto Ishikawa, Yoichiro Masuda, Hitoshi Ishikawa, et al.
Journal of Radiation Research|May 28, 2014
High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II studyYoshiko Oshiro, Toshiyuki Okumura, Koichi Kurishima, et al.
Advances in Radiation Oncology|November 17, 2025
Carbon Ion Versus Photon-based Stereotactic Ablative Radiation Therapy for Patients with Choroidal MelanomaJina Kim, Masaru Wakatsuki, Shuri Aoki, et al.
Cancers|September 27, 2025
Carbon-Ion Radiotherapy for Prostate Cancer in Patients with a History of Surgery for Benign Prostatic HyperplasiaAtsushi Okato, Kosei Miura, Tomoki Yamaguchi, et al.
Japanese Journal of Ophthalmology|October 29, 2024
Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in JapanYohei Takahashi, Takeshi Kezuka, Keigo Shikishima, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2023
Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG)Nobuteru Kubo, Hiroaki Suefuji, Mio Nakajima, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Long-Term Outcomes of Ocular and Visual Preservation After Carbon Ion Radiation Therapy for Choroidal Malignant MelanomaShuri Aoki, Masaru Wakatsuki, Hiroshi Tsuji, et al.
International Journal of Clinical Oncology|October 10, 2019
A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinomaYoshiyuki Nagumo, Takahiro Kojima, Masanobu Shiga, et al.
Annals of Clinical Biochemistry|April 4, 2015
Simple quantitation for potential serum disease biomarker peptides, primarily identified by a peptidomics approach in the serum with hypertensive disorders of pregnancyKensuke Hamamura, Daisuke Nonaka, Hitoshi Ishikawa, et al.
Pageof 41